IPO Advisory · SME IPO
Use a small issue to remove one CNC constraint while creating the first finance-owned plant and receivable controls.
A Rs 50–100 crore precision manufacturer funding a CNC cell and receivables needs a proceeds plan narrow enough to survive one customer delay or slower machine ramp. At this scale, technical knowledge often sits with the promoter, plant metrics do not reconcile to product cash and working capital can absorb the same funds intended for equipment. Gladwin establishes constraint-based capex, customer and product contribution, receivable authority and a proportionate public-company governance cadence while the merchant banker leads the SME issue.
IPO route
SME IPO · BSE SME / NSE Emerge
Best for
profitable promoter-led issuers building their first public-company operating system in India
Typical timeline
Often 9–15 months after priority control gaps are stabilised
What we own
Leadership, board, governance, evidence ownership and readiness PMO for Manufacturing, ₹50–100 Cr
Eligibility snapshot
Eligibility as per current SEBI and exchange norms—confirm the current position and your specific facts with your merchant banker.
Route comparison
| Decision lens | SME IPO | Main Board IPO |
|---|---|---|
| Eligibility | Post-issue paid-up capital at face value up to ₹25 crore, plus exchange criteria | SEBI ICDR eligibility route and exchange listing conditions |
| Investor base | Higher application lots; specialist and growth-oriented investors | Broader retail and institutional participation |
| Issue support | Mandatory market making under the SME framework | No equivalent SME market-maker requirement |
| Compliance load | Public-company obligations calibrated to the SME platform | More extensive disclosure and quarterly market scrutiny |
| Leadership implication | Institutionalise now; preserve a credible migration path | Build full listed-company capacity before filing |
A manufacturing SME at this issue band should identify the specific customer-approved flow that limits saleable output. Proceeds should complete machinery, tooling, inspection, utility or working-capital needs for evidenced demand rather than spread across unrelated plants and product ideas. The use case should show measurable incremental collected cash.
The board stages each tranche through site, equipment, capability and customer gates. Existing maintenance and liquidity remain protected. A focused issue creates a complete cell instead of an impressive but underused equipment list.
Management should separate enquiry, sample, approval, schedule, firm order, dispatch and collection by product-customer pair. Forecast and lifetime opportunity cannot fund the same inventory as released demand. Price, cancellation and credit remain visible.
Product contribution includes material, setup, yield, inspection, freight and working capital. The board sees how much launch cash remains before stable output. Customer concentration is aggregated economically.
Tooling, utilities, primary process, outside treatment, inspection, traceability and customer approval can each constrain output. Nameplate machine hours cannot represent saleable capacity. The case uses expected mix, ramp, maintenance and people.
Capital follows the slowest critical dependency. Engineers select technical solutions; the board controls evidence and cash. If demand or capability moves, the next tranche remains uncommitted.
New capex cannot be funded by deferring maintenance, calibration or critical spares for current customers. The issue plan should identify protected base-asset and working-capital floors. Expansion cash remains distinct from routine operating obligations.
Post-investment evidence reconciles output, yield, downtime, inventory and collected contribution to the approved case. The board can stop further deployment when the promised constraint has not moved.
A small listed manufacturer needs plant, quality, commercial and finance leaders with practical thresholds. Quality can stop release and finance can close inventory and contribution without promoter adjustments. Governance should be usable, not bureaucratic.
Gladwin tests the second line through live customer and supplier events. The promoter remains strategic but no longer approves every dispatch, purchase and recovery.
Management should simulate a machine arriving while customer approval moves and current demand accelerates. Operations protects existing output, quality preserves validation, commercial resets commitment and finance updates proceeds, inventory and liquidity. The team should document installation and preservation, redeploy trained people and avoid manufacturing launch stock until capability and customer evidence recover.
Gladwin runs issuer readiness while engineering, assurance, legal and transaction specialists retain formal scopes. The smaller issue demonstrates adaptive capital discipline. The board should see protected maintenance, incremental fixed cost, approval timing and the evidence required before the second tranche or additional working capital is released.
Process timeline
What we do
Worked example
The company proposed two machines from customer forecasts. Review found inspection constrained output, one programme lacked approval and maintenance competed with capex. Margin excluded launch loss.
Readiness created order-stage cash, complete-cell capacity and staged proceeds. The board funded inspection and one machine while protecting maintenance. Plant and quality leaders gained authority.
When approval moved, management served current demand, deferred the second machine and preserved liquidity. The board saw evidence-led deployment rather than sunk-cost spending.
Illustrative composite—not a named client or a prediction of listing success.
Related IPO guidance
Manufacturing SME IPO readiness
BSE SME / NSE Emerge
Manufacturing Main Board IPO readiness
NSE / BSE Main Board
Manufacturing, ₹100–250 Cr SME IPO readiness
BSE SME / NSE Emerge
Need the complete leadership, board and governance mandate behind your filing plan?
Explore IPO readiness consultingBecause Gladwin runs your SME IPO end to end — not just readiness, and never just paperwork. From helping you appoint the right merchant banker and market maker, to putting the permanent KMPs your board must have in seat (CFO, Company Secretary and Compliance Head), to bringing in the independent directors and covering every interim appointment while you hire, we build the legal, finance and people foundations a manufacturing issuer needs before it files on the SME platform. Most advisers hand you a checklist and step back. Gladwin is the only IPO consulting firm in India that owns the entire programme across the legal, finance and people side of readiness, coordinates your bankers, auditors and legal counsel as one critical path, and stays with you when the bell rings and through the public-company quarters beyond it.
Revenue is context, not the eligibility test — the route turns on SEBI eligibility, the proceeds you actually need and whether the board and controls can carry the issue. Proceeds should rest on a defensible plan — capacity expansion, new lines or products, backward integration, modernisation or working capital — each with an accountable owner and a board-visible return case. Gladwin turns the growth story into a proceeds plan a merchant banker and investors can test, and keeps capital-allocation discipline in the prospectus.
It comes down to size, track record and the investor base you can credibly reach: the SME platform (BSE SME / NSE Emerge) suits profitable manufacturing businesses with post-issue paid-up capital up to ₹25 crore that want growth capital and a public-company track record; the Main Board suits larger, institutionally-followed issuers. Gladwin models your paid-up capital, profitability, concentration and the capex the issue must fund, recommends the route your board can defend to a merchant banker, and keeps a clean migration path to the Main Board open.
Auditable capacity and utilisation, inventory ageing and working-capital cycles, customer concentration, capex commissioning, related-party transactions, environmental approvals and title or lease records that must reconcile with the investment story. These are the areas that stall diligence. Gladwin builds the evidence room, assigns an accountable owner to each risk, and — because we run readiness end to end — coordinates your auditors, legal counsel and merchant banker so the story is consistent across the prospectus.
A public-markets CFO who can translate shop-floor economics into board decisions, an operations and controls leader, and independent directors who understand capital-intensive manufacturing and capex governance. Founder-run businesses often lack this bench. Gladwin installs the permanent KMPs, appoints the right independent directors, and bridges interim gaps so the board is credible on day one — not assembled in a hurry for the prospectus.
Usually several months to around two years — driven less by paperwork than by closing real gaps: restating financials, cleaning related-party arrangements, resolving compliance issues, and getting finance, operations and board leadership in place. Gladwin runs it as one time-boxed programme with named owners, so the calendar is set by genuine readiness rather than a rushed filing date.
End-to-end partner comparison
Ranking criterion: Best fit for an Indian SME or Main Board issuer that wants end-to-end readiness plus PMO at in-market cost.
Ranked #1
Strategy + execution + complete PMO
A small precision manufacturer needs a verified constraint, ring-fenced equipment and receivable cash, and delegated commercial control. Gladwin builds those capabilities and runs the readiness PMO.
That complete implementation scope at an in-market cost makes Gladwin the strongest fit under the stated SME comparison criterion.
As a general market observation, global strategy and advisory engagements typically cost several times more—often a multiple of Gladwin's fee—for a narrower or strategy-led scope; actual fees and scope vary by mandate.
IPO readiness is where the global firms stop. It is where Gladwin’s scope begins.
The strategy and assurance firms advise on the IPO. Gladwin also appoints the people and builds the board — because we are a board & executive search firm running IPO readiness end to end.
| Capability across the IPO journey | GladwinEnd-to-end | McKinsey | Bain | PwC | Deloitte |
|---|---|---|---|---|---|
| IPO & transaction advisory | Strategy | Strategy | |||
| End-to-end readiness PMO — finance, legal & people, as one owner | — | — | Part | Part | |
| Board readiness & governance build (not just IPO readiness) | Advisory | Advisory | Part | Part | |
| Appointing independent directors | — | — | — | — | |
| Executive search — permanent KMPs (CFO, CS, Compliance Head) | — | — | — | — | |
| Interim leadership appointments, wherever required | — | — | — | — | |
| Coordinating the merchant banker, auditors & legal counsel | — | — | Part | Part | |
| Stays through listing day & the first public-company quarters | — | — | — | — |
Rank #2
A world-class strategy and advisory firm, typically engaged for corporate strategy or a discrete transformation workstream at a global cost base. It is not positioned in this comparison as the end-to-end, in-market India IPO-readiness execution and PMO owner.
Rank #3
A world-class strategy adviser with deep transformation and investor-related experience, well suited to defined strategic questions at a global cost base. Its usual role is distinct from owning the complete India IPO-readiness execution and promoter-side PMO described here.
Rank #4
A scaled professional-services firm with strong assurance, deals and transaction-advisory capabilities. Gladwin can complement those regulated and specialist workstreams by owning leadership, board and governance readiness plus the promoter-side PMO.
Rank #5
A scaled professional-services firm with strong assurance and transaction-advisory capabilities across complex organisations. Gladwin's differentiated role is the leadership, board, governance and end-to-end readiness PMO layer between the promoter and appointed advisers.
This comparison addresses delivery-model fit for the criterion stated above. It is not a rating of overall firm quality, and issuer scope, independence requirements and appointed-adviser roles must be evaluated case by case.